In Vitro Skin Permeation Methodology

Transdermal and Topical Drug Delivery: Principles and Practice

Volumn , Issue , 2012, Pages 85-108

  Finnin, Barrie ^a   Walters, Kenneth A ^b   Franz, Thomas J ^c  

^a MONASH UNIVERSITY   (Australia)

^b An eX Analytical Services Ltd   (United Kingdom)

^c Cetero Research   (United States)

Author keywords

Human skin, and in vitro permeation, in use or real practical behavior; Skin metabolism impact on in vitro skin perfusion, twofold; Skin viability and metabolic activity, with special receptor solutions

Indexed keywords

EID: 84886023853     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118140505.ch5     Document Type: Chapter

References (95)

1. Organisation for Economic Cooperation and Development. OECD Guideline for Testing of Chemicals No. 428: Skin Absorption: In Vitro Methods. OECD, Paris, France, 2004; 1-8.
2. Organisation for Economic Cooperation and Development. OECD Series on Testing and Assessment No. 28: Guidance Document for the Conduct of Skin Absorption Studies. OECD. 2004: 1-31.
3. Chilcott RP, Barai N, Beezer AE, Brain SI, Brown MB, Bunge AL, Burgess SE, Cross S, Dalton CH, Dias M, Farinha A, Finnin BC, Gallagher SJ, Green DM, Gunt H, Gwyther RL, Heard CM, Jarvis CA, Kamiyama F, Kasting GB, Ley EE, Lim ST, McNaughton GS, Morris A, Nazemi MH, Pellett MA, Du Plessis J, Quan YS, Raghavan SL, Roberts M, Romonchuk W, Roper CS, Schenk D, Simonsen L, Simpson A, Traversa BD, Trottet L, Watkinson A, Wilkinson SC, Williams FM, Yamamoto A, Hadgraft J. Inter-and intralaboratory variation of in vitro diffusion cell measurements: An international multicenter study using quasi-standardized methods and materials. Journal of Pharmaceutical Sciences 2005; 94: 632-638.
4. van de Sandt JJ, van Burgsteden JA, Cage S, Carmichael PL, Dick I, Kenyon S, Korinth G, Larese F, Limasset JC, Maas WJ, Montomoli L, Nielsen JB, Payan JP, Robinson E, Sartorelli P, Schaller KH, Wilkinson SC, Williams FM. In vitro predictions of skin absorption of caffeine, testosterone, and benzoic acid: A multi-centre comparison study. Regulatory and Toxicological Pharmacology 2004; 39: 271-281.
5. Scheuplein RJ, Blank IH. Permeability of the skin. Physiological Reviews 1971; 51: 702-747.
6. Franz TJ. Percutaneous absorption: On the relevance of in vitro data. Journal of Investigative Dermatology 1975; 64: 190-195.
7. Franz TJ. The fi nite dose technique as a valid in vitro model for the study of percutaneous absorption in man. In: Simon GA, Paster A, Klingberg M, Kaye M, eds. Skin: Drug Application and Evaluation of Environmental Hazards. Current Problems in Dermatology. Karger, Basel, Switzerland, 1978; 58-68.
8. Bronaugh RL, Stewart RF. Methods for in vitro percutaneous absorption studies. IV. The fl ow-through diffusion cell. Journal of Pharmaceutical Sciences 1985; 74: 64-67.
9. Holland JM, Kao JY, Whitaker MJ. A multisample apparatus for kinetic evaluation of skin penetration in vitro: The infl uence of viability and metabolic status of the skin. Toxicology and Applied Pharmacology 1984; 72: 272-280.
10. Collier SW, Sheikh NM, Sakr A, Lichtin JL, Stewart RF, Bronaugh RL. Maintenance of skin viability during in vitro percutaneous absorption/metabolism studies. Journal of Toxicology and Applied Pharmacology 1989; 99: 522-533.
11. Bronaugh RL, Stewart RF. Methods for in vitro percutaneous absorption studies. III. Hydrophobic compounds. J ournal of Pharmaceutical Sciences 1984; 73: 1255-1258.
12. Bronaugh RL, Stewart RF. Methods for in vitro percutaneous absorption studies: VI. Preparation of the barrier layer. Journal of Pharmaceutical Sciences 1986; 75: 1094-1097.
13. Scott RC, Ramsey JD. Comparison of the in vivo and in vitro percutaneous absorption of a lipophilic molecule (cypermethrin, a pyrethroid insecticide). Journal of Investigative Dermatology 1987; 89: 142-146.
14. Ramsey JD, Woollen BH, Auton TR, Scott RC. The predictive accuracy of in vitro measurements for the dermal absorption of a lipophilic penetrant (fl uazifop-butyl) through rat and human skin. Fundamental and Applied Toxicology 1994; 23: 230-236.
15. Ramsey JD, Woollen BH, Auton TR, Batten TR, Leeser PL. Pharmacokinetics of fl uazifop-butyl in human volunteers. II. Dermal dosing. Human and Experimental Toxicology 1992; 11: 247-254.
16. Bronaugh RL, Franz TJ. Vehicle effect on percutaneous absorption: In vivo and in vitro comparisons. British Journal of Dermatology 1986; 115: 1-11.
17. Bronaugh RL, Stewart RF, Congdon ER. Methods for in vitro percutaneous absorption studies. II: Animal models for human skin. Toxicology Applied Pharmacology 1982; 62: 481-488.
18. Barbero AM, Frasch HF. Pig and guinea pig skin as surrogates for human in vitro penetration studies: A quantitative review. Toxicology in Vitro 2009; 23: 1-13.
19. Eppler AR, Kraeling ME, Wickett RR, Bronaugh RL. Assessment of skin absorption and irritation potential of arachidonic acid and glyceryl arachidonate using in vitro diffusion cell techniques. Food and Chemical Toxicology 2007; 45: 2109-2117.
20. Southwell JD, Barry BW, Woodford R. Variations in permeability of human skin within and between specimens. International Journal of Pharmaceutics 1984; 18: 299-309.
21. Benfeldt E, Hansen SH, Volund A, Menne T, Shah VP. Bioequivalence of topical formulations in humans: Evaluation by dermal microdialysis sampling and the dermatopharmacokinetics method. Journal of Investigative Dermatology 2007; 127: 170-178.
22. Tettey-Amlalo RN, Kanfer I, Skinner MF, Benfeldt E, Verbeeck RK. Application of dermal microdialysis for the evaluation of bioequivalence of a ketoprofen topical gel. European Journal of Pharmaceutical Sciences 2009; 36: 219-225.
23. Williams AC, Cornwell PA, Barry BW. On the non-Gaussian distribution of human skin permeabilities. International Journal of Pharmaceutics 1992; 86: 69-77.
24. Chiou YB, Blume-Peytavi U. Stratum corneum maturation: A review of neonatal skin function. Skin Pharmacology and Physiology 2004; 17: 57-66.
25. Nicolovski J, Stamatas GN, Kollias N, Wiegand BC. Barrier function and water-holding and transport properties of infant stratum corneum are different from adult and continue to develop through the fi rst year of life. Journal of Investigative Dermatology 2008; 128: 1728-1736.
26. Takahashi M, Watanabe H, Kumagai H, Nakayama Y. Physiological and morphological changes in facial skin with aging. Journal of the Society of Cosmetic Chemists Japan 1989; 23: 22-30.
27. Marrakchi S, Maibach HI. Sodium lauryl sulfate-induced irritation in the human face: Regional and age-related differences. Skin Pharmacology and Physiology 2006; 19: 177-180.
28. Roskos KV, Maibach HI, Guy RH. The effect of ageing on percutaneous absorption in man. Journal of Pharmacy and Biopharmaceutics 1989; 17: 617-630.
29. Solassol I, Caumette L, Bressolle F, Garcia F, Thezenas S, Astre C, Culine S, Coulouma R, Pinguet F. Inter-and intra-individual variability in transdermal fentanyl absorption in cancer pain patients. Oncology Reports 2005; 14: 1029-1036.
30. Grove GL. Physiologic changes in older skin. Clinical Geriatric Medicine 1989; 5: 115-125.
31. Roskos KV, Bircher AJ, Maibach HI, Guy RH. Pharmacodynamic measurements of methyl nicotinate percutaneous absorption: The effect of aging on microcirculation. British Journal of Dermatology 1990; 122: 165-171.
32. Farage MA, Miller KW, Elsner P, Maibach HI. Intrinsic and extrinsic factors in skin ageing: A review. International Journal of Cosmetic Science 2008; 30: 87-95.
33. Elias PM, Ghadially R. The aged epidermal permeability barrier: Basis for functional abnormalities. Clinical Geriatric Medicine 2002; 18: 103-120.
34. Jensen JM, Fori M, Winoto-Morbach S, Seite S, Schunck M, Proksch E, Schutze S. Acid and neutral sphingomyelinase, ceramide synthase, and acid ceramidase activities in cutaneous aging. Experimental Dermatology 2005; 14: 609-618.
35. Choi EH, Man MO, Xu P, Xin S, Liu Z, Crumrine DA, Jiang YJ, Fluhr JW, Feingold KR, Elias PM, Mauro TM. Stratum corneum acidifi cation is impaired in moderately aged human and murine skin. Journal of Investigative Dermatology 2007; 127: 2847-2856.
36. Sridevi S, Diwan PV. Optimized transdermal delivery of ketoprofen using pH and hydroxypropyl-b-cyclodextrin as co-enhancers. European Journal of Pharmacy and Biopharmaceutics 2002; 54: 151-154.
37. Huang ZR, Hung CF, Lin YK, Fang JY. In vitro and in vivo evaluation of topical delivery and potential dermal use of soy isofl avones genistein and daidzein. International Journal of Pharmaceutics 2008; 364: 36-44.
38. Sauermann K, Clemann S, Jaspers S, Gambichler T, Altmeyer P, Hoffmann K, Ennen J. Age related changes of human skin investigated with histometric measurements by confocal laser scanning microscopy in vivo. Skin Research Technology 2002; 8: 52-56.
39. Holowatz LA, Thompson-Torgerson CS, Kenney WL. Altered mechanisms of vasodilation in aged human skin. Exercise and Sport Science Review 2007; 35: 119-125.
40. Cross SE, Roberts MS. Use of in vitro human skin membranes to model and predict the effect of changing blood fl ow on the fl ux and retention of topically applied solutes. Journal of Pharmaceutical Sciences 2008; 97: 3442-3450.
41. Marzulli FN, Maibach HI. Permeability and reactivity of skin as related to age. Journal of the Society of Cosmetic Chemists 1984; 35: 95-102.
42. Roskos KV, Maibach HI. Percutaneous absorption and age: Implications for therapy. Drugs Aging 1992; 2: 432-449.
43. Wedig JH, Maibach HI. Percutaneous penetration of dipyrithione in man: Effect of skin color (race). Journal of the American Academy of Dermatology 1981; 5: 433-438.
44. Kompaore F, Marty J-P, Dupont C. In vivo evaluation of the stratum corneum barrier function in Blacks, Caucasians and Asians with two noninvasive methods. Skin Pharmacology 1993; 6: 200-207.
45. Weigand DA, Haygood C, Gaylor JR. Cell layers and density of negro and Caucasian SC. Journal of Investigative Dermatology 1974; 62: 563-568.
46. Rienertson RP, Wheatley VR. Studies on the chemical composition of human epidermal lipids. Journal of Investigative Dermatology 1959; 32: 49-59.
47. Mangelsdorf S, Otberg N, Maibach HI, Sinkgraven R, Sterry W, Lademann J. Ethnic variation in vellus hair follicle size and distribution. Skin Pharmacology and Physiology 2006; 19: 159-167.
48. Leopold CS, Maibach HI. Effect of lipophilic vehicles on in vivo skin penetration of methyl nicotinate in different races. International Journal of Pharmaceutics 1996; 139: 161-167.
49. Wickrema Sinha AJ, Shaw SR, Weber DJ. Percutaneous absorption and excretion of tritium-labeled difl orasone diacetate, a new topical corticosteroid in the rat, monkey and man. Journal of Investigative Dermatology 1978; 71: 372-377.
50. Lotte C, Wester RC, Rougier A, Maibach HI. Racial differences in the in vivo percutaneous absorption of some organic compounds: A comparison between black, Caucasian and Asian subjects. Archives of Dermatological Research 1993; 284: 456-459.
51. Rawlings AV. Ethnic skin types: Are there differences in skin structure and function? International Journal of Cosmetic Science 2006; 28: 79-93.
52. Harrison SM, Barry BW, Dugard PH. Effects of freezing on human skin permeability. Journal of Pharmacy and Pharmacology 1984; 36: 261-262.
53. Kasting GB, Bowman LA. Electrical analysis of fresh excised human skin: A comparison with frozen skin. Pharmaceutical Research 1990; 7: 1141-1146.
54. Wester RC, Christoffel J, Hartway T, Poblete N, Maibach HI, Forsell J. Human cadaver skin viability for in vitro percutaneous absorption: Storage and detrimental effects of heat-separation and freezing. Pharmaceutical Research 1998; 15: 82-84.
55. Sintov AC, Botner S. Transdermal drug delivery using microemulsion and aqueous systems: Infl uence of skin storage conditions on the in vitro permeability of diclofenac from aqueous vehicle systems. International Journal of Pharmaceutics 2006; 311: 55-62.
56. Ahlstrom LA, Cross SE, Mills PC. The effects of freezing skin on transdermal drug penetration kinetics. Journal of Veterinary Pharmacology and Therapeutics 2007; 30: 456-463.
57. Brain KR, Walters KA, Watkinson AC. Methods for studying percutaneous absorption. In: Walters KA, ed. Dermatological and Transdermal Formulations. Marcel Dekker, New York, 2002 ; 197-269.
58. Walters KA, Brain KR, Howes D, James VJ, Kraus AL, Teetsel NM, Toulon M, Watkinson AC, Gettings SD. Percutaneous penetration of octyl salicylate from representative sunscreen formulations through human skin in vitro. Food and Chemical Toxicology 1997; 35: 1219-1225.
59. Okamoto H, Komatsu H, Hashida M, Sezaki H. Effects of ß-cyclodextrin and di-O-methyl-ß-cyclodextrin on the percutaneous absorption of butylparaben, indomethacin and sulfanilic acid. International Journal of Pharmaceutics 1986; 30: 35-45.
60. Díez-Sales O, Watkinson AC, Herráez-Dominguez M., Javaloyes C, Hadgraft J. A mechanistic investigation of the in vitro human skin permeation enhancing effect of Azone ®. International Journal of Pharmaceutics 1996; 129: 33-40.
61. Pannatier A, Jenner P, Testa B, Etter JC. The skin as a drug-metabolizing organ. Drug Metabolism Reviews 1978; 8: 319-343.
62. Bickers DR, Dutta-Choudhury T, Mukhtar H. Epidermis: Site of drug metabolism in neonatal rat skin. Studies on cytochrome P-450 content and mixed function oxidase and epoxide hydrolase activity. Molecular Pharmacology 1982; 21: 239-247.
63. Martin RJ, Denyer SP, Hadgraft J. Skin metabolism of topically applied compounds. International Journal of Pharmaceutics 1987; 39: 23-32.
64. Zhang Q, Grice JE, Wang G, Roberts MS. Cutaneous metabolism in transdermal drug delivery. Current Drug Metabolism 2009; 10: 227-235.
65. Steinsträsser I, Merkle HP. Dermal metabolism of topically applied drugs: Pathways and models reconsidered. Pharmaceutica Acta Helvetiae 1995; 70: 3-24.
66. Kao J, Carver MP. Cutaneous metabolism of xenobiotics. Drug Metabolism Reviews 1990; 22: 363-410.
67. Baron JM, Wiederholt T, Heise R, Merk HF, Bickers DR. Expression and function of cytochrome P450-dependent enzymes in human skin cells. Current Medicinal Chemistry 2008; 15: 2258-2264.
68. Finnen MJ, Shuster S. Phase I and phase 2 drug metabolism in isolated epidermal cells from adult hairless mice and in whole human hair follicles. Biochemical Pharmacology 1985; 34: 3571-3575.
69. Täuber U. Metabolism of drugs on and in the skin. In: Brandau R, Lippold BH, eds. Dermal and Transdermal Absorption. Wissenschaftliche Verlagsgesellschaft, Stuttgart, Germany, 1982 ; 133-151.
70. Fruton JS. On the proteolytic enzymes of animal tissues. Journal of Biological Chemistry 1946 ; 166: 721-738.
71. Oesch F, Fabian E, Oesch-Bartlomowicz B, Werner C, Landsiedel R. Drug-metabolizing enzymes in the skin of man, rat, and pig. Drug Metabolism Reviews 2007; 39: 659-698.
72. Nohynek GJ, Antignac E, Re T, Toutain H. Safety assessment of personal care products/cosmetics and their ingredients. Toxicology and Applied Pharmacology 2010; 243: 239-259.
73. Kao J, Hall J. Skin absorption and cutaneous fi rst pass metabolism of topical steroids: In vitro studies with mouse skin in organ culture. The Journal of Pharmacology and Experimental Therapeutics 1987; 241: 482-487.
74. Bucks DAW. Skin structure and metabolism: Relevance to the design of cutaneous therapies. Pharmaceutical Research 1984; 1: 148-153.
75. Fang JY, Leu YL. Prodrug strategy for enhancing drug delivery via skin. Current Drug Discovery Technology 2006; 3: 211-224.
76. Gusek DB, Kennedy AH, McNeill SC, Wakshull E, Potts RO. Transdermal drug transport and metabolism. I. Comparison if in vitro and in vivo results. Pharmaceutical Research 1989; 6: 33-39.
77. Potts RO, McNeill SC, Desbonnet CR, Wakshull E. Transdermal drug transport and metabolism. II The role of competing kinetic events. Pharmaceutical Research 1989; 6: 119-124.
78. Choi H-K, Flynn GL, Amidon GL. Transdermal delivery of bioactive peptides: The effect of n-decylmethyl sulfoxide, pH, and inhibitors on enkephalin metabolism and transport. Pharmaceutical Research 1990; 7: 1099-1106.
79. Brookes FL, Hugo WB, Denyer SP. Transformation of betamethasone 17-valerate by skin microfl ora. Proceedings of the British Pharmaceutical Conference, Edinburgh, 1982.
80. Denyer SP, Hugo WB, O'Brien M. Metabolism of glyceryl trinitrate by skin staphylococci. Journal of Pharmacy and Pharmacology 1984; 36: 61P.
81. Denyer SP, Guy RH, Hadgraft J, Hugo WB. The microbial degradation of topically applied drugs. International Journal of Pharmaceutics 1985; 26: 89-97.
82. Liu P, Higuchi WI, Ghanem A-H, Kurihara-Bergstrom T, Good WR. Quantitation of simultaneous diffusion and metabolism of ß=estradiol in hairless mouse skin: Enzyme distribution and intrinsic diffusion/metabolism parameters. International Journal of Pharmaceutics 1990; 64: 7-25.
83. Wilton Coomes M, Norling AH, Pohl RJ, Mü ller D, Fouts JR. Foreign compound metabolism by isolated skin cells from the hairless mouse. The Journal of Pharmacology and Experimental Therapeutics 1983; 225: 770-777.
84. Merk HF, Mukhtar H, Schutte B, Kaufmann I, Das M, Bickers DR. 7-ethoxyresorufi n-o-deethylase activity in human hair roots: A potential marker for toxifying species of cytochrome P-450 isozymes. Biochemical Biophysical Research Communications 1987; 148: 755-761.
85. Hsia SL, Mussallem AJ, Witten VH. Further metabolic studies of hydrocortisone-4-14C in human skin. The Journal of Investigative Dermatology 1965; 45: 384-388.
86. Lodén M. The in vitro hydrolysis of diisopropyl fl uoro-phosphate during penetration through human full-thickness skin and isolated epidermis. The Journal of Investigative Dermatology 1985; 85: 335-339.
87. Thompson S, Slaga TJ. Mouse epidermal aryl hydrocarbon hydroxlase. The Journal of Investigative Dermatology 1976; 66: 108-111.
88. Hsia SL, Hao Y-L. Metabolic transformations of cortisol-4[14C] in human skin. Biochemistry 1966 ; 5: 1469-1464.
89. Weinstein GD, Frost P, Hsia SL. In vitro interconversion of estrone and 17 ß-estradiol in human skin and vaginal mucosa. The Journal of Investigative Dermatology 1968; 51: 4-10.
90. Hewitt PG, Perkins J, Hotchkiss SAM. Metabolism of fl uroxypyr, fl uroxypyr methyl ester, and the herbicide fl uroxypyr methylheptyl ester I: During percutaneous absorption through fresh rat and human skin in vitro. Drug Metabolism and Disposition 2000; 28: 748-754.
91. Storm JE, Bronough RL, As C, Simmons JE. Cutaneous metabolism of nitroglycerin in viable rat skin in vitro. International Journal of Pharmaceutics 1990; 65: 265-268.
92. Fox JL, Yu C-D, Higuchi WI, Ho NFH. General physical model for simultaneous diffusion and metabolism in biological membranes. The computational approach for the steady-state case. International Journal of Pharmaceutics 1979; 2: 41-57.
93. Hadgraft J. Theoretical aspects of metabolism in the epidermis. International Journal of Pharmaceutics 1980; 4: 229-239.
94. Sugibayashi K, Hayashi T, Htanaka T, Ogihara M, Morimoto Y. Analysis of simultaneous transport and metabolism of ethyl nicotinate in hairless rat skin. Pharmaceutical Research 1996; 13: 855-860.
95. Boderke P, Schittkowski K, Wolff M, Merkle HP. Modelling of diffusion and concurrent metabolism in cutaneous tissue. Journal of Theoretical Biology 2000; 204: 393-407.